Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the safety and tolerability and pharmacokinetics of
a single intravenous administration of the new, Sulfobutyl Ether-7-Beta-Cyclodextrin
(Captisol™) based, formulation in Healthy Adult Subjects.